Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil vs Standard Surgical Treatment for Pulmonary Air Leakage
NCT00293514Phase 3Completed
- Sponsor
- Nycomed
- Start
- Feb 2006
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of tachosil in Pulmonary air-leak syndrome (PALS), sponsored by Nycomed. Started Feb 2006; status: completed.
02
Drugs
tachosil
03
Conditions
Pulmonary air-leak syndrome (PALS)
Beyond the preview
Go deeper on NCT00293514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00293514.